Stem cells have a reputation as a “difficult” area of patents, involving technological and moral considerations that go beyond “normal” issues of patentability.
This webinar will provide an introduction to issues concerning the patentability of stem cells in Europe and further afield. It will address technical considerations, as well as the various specific legal considerations, based on practical advice gained over years of working in this area. It will be particularly useful to those who are training, or have recently qualified, and are beginning drafting and prosecution in this area. It should also serve as a useful summary for seasoned practitioners wishing to stay abreast of the latest thinking.
Iain Armstrong is a partner in HGF’s Life Sciences team. Iain’s practice covers a wide range of biotechnological inventions, particularly specialising in inventions relating to the therapeutic application of biotechnology. With nearly 20 years’ experience in the patent profession, he has drafted and prosecuted a huge number of specifications in the biotechnology field. Iain has a particular interest in stem cell-based inventions, acting for a number of domestic and overseas clients in this area.